A Phase-I Study of the Safety, Pharmacokinetics, and Antiviral Activity of Combination Didanosine and Ribavirin in Patients with HIV-1 Disease-Reference-Cited by-同舟云学术

A Phase-I Study of the Safety, Pharmacokinetics, and Antiviral Activity of Combination Didanosine and Ribavirin in Patients with HIV-1 Disease

Published:1996-11 Issue:3 Volume:13 Page:235-246
ISSN:1077-9450
Container-title:Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
language:en
Short-container-title:Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Author:

Japour Anthony J.,Lertora Juan J.,Meehan Patricia M.,Erice Alejo,Connor James D.,Griffith Brigitte P.,Clax Pamela A.,Holden-Wiltse Jeanne,Hussey S.,Walesky Mary,Cooney Elizabeth,Pollard Richard,Timpone Joseph,McLaren Colin,Johanneson Nils,Wood Kenneth,Booth David K.,Bassiakos Yannis

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Virology,Immunology,Immunology and Allergy

Reference30 articles.

1. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.

2. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.

3. Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity

4. Rapid and sensitive viral culture method for human immunodeficiency virus type 1

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ribavirin;Meyler's Side Effects of Drugs;2016

2. Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever;Future Virology;2015-05

3. Drug-Drug Interactions Among Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Medications;Infectious Diseases and Therapy;2015-04-21

4. Infections with Multiple Hepatotropic Viruses;Polymicrobial Diseases;2014-04-08

5. Tratamiento de la hepatitis por virus C en pacientes coinfectados por el virus de la inmunodeficiencia humana;Gastroenterología y Hepatología;2011-10